Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

13.2K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
13.2K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

16.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
16.3K
Cofactors and Coenzymes01:27

Cofactors and Coenzymes

89.7K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
89.7K
Cofactors and Coenzymes01:24

Cofactors and Coenzymes

13.6K
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
13.6K
Cofactors and Coenzymes01:27

Cofactors and Coenzymes

9.4K
9.4K
Coagulation01:09

Coagulation

12.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemically delivered mRNA-LNPs transfect primary and secondary liver tumors.

Molecular therapy. Nucleic acids·2026
Same author

TGMS-UNet: A dual-branch segmentation network for ultrasound endometrium based on sequence guidance and multi-scale feature correction.

Digital health·2026
Same author

Ultrasound-driven mechanical immunomodulation enhances tumor treatment sensitivity: advances from tumor mechanical immunobiology to immunotherapy applications.

Frontiers in immunology·2026
Same author

Targeting glutathione metabolism for tumor radiosensitization (Review).

International journal of molecular medicine·2026
Same author

Engineering cell ring organoids for efficient establishment of patient-derived orthotopic xenotransplantation (r-PDOX) model in sarcoma.

Biomaterials·2026
Same author

Synthesis and Biochemical Characterization of Investigational Pyrazolopyrimidine-Based Allosteric KRAS Modulators.

ACS medicinal chemistry letters·2026

Related Experiment Video

Updated: Apr 21, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

12.0K

von Willebrand factor is a cofactor in complement regulation.

Shuju Feng1, Xiaowen Liang2, Michael H Kroll1

  • 1Section of Benign Hematology, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX;

Blood
|November 15, 2014
PubMed
Summary

Normal von Willebrand factor (VWF) prevents complement activation by aiding C3b cleavage. Large VWF multimers, found in thrombotic microangiopathy, do not inhibit complement, allowing activation.

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.6K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

11.4K

Related Experiment Videos

Last Updated: Apr 21, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

12.0K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.6K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

11.4K

Area of Science:

  • Immunology
  • Hematology
  • Biochemistry

Background:

  • Complement proteins and hemostatic factors interact.
  • Von Willebrand factor (VWF) is a key hemostatic factor with potential roles in complement regulation.

Purpose of the Study:

  • To investigate the role of VWF in complement regulation.
  • To determine how different VWF multimer sizes affect complement activation.

Main Methods:

  • In vitro assays measuring factor I-mediated cleavage of C3b.
  • Analysis of VWF multimer size distribution.

Main Results:

  • VWF acts as a cofactor for factor I, promoting C3b cleavage and inhibiting complement activation.
  • Smaller VWF multimers enhance C3b cleavage, while large and ultra-large VWF (ULVWF) multimers do not.
  • ULVWF multimers, found in thrombotic microangiopathy, permit complement activation.

Conclusions:

  • Normal plasma VWF regulates complement activation by promoting C3b inactivation.
  • ULVWF multimers lack inhibitory function on complement, contributing to complement-mediated pathology in thrombotic microangiopathy.